---
title: We've Reached 5000 Patients!
description: FidoCure celebrates reaching 5000 cases of dog patients studied for cancer research in pets and humans.
image: https://blog.fidocure.com/hubfs/Twitter%20banner%205000%20cases%20(1).png
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
# We've Reached 5000 Patients!
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases)
We are thrilled to share with you an incredible milestone in our journey to revolutionize canine cancer treatment. Thanks to your unwavering support and dedication, we have now enrolled over **5,000 dogs** in the FidoCure platform! This achievement is a testament to the trust you have placed in our innovative approach and the positive impact we are making together in the lives of dogs and their families.
Since 2016, FidoCure has been at the forefront of cutting-edge research in canine cancer treatment. The 5,000 brave dogs enrolled in our platform have not only received personalized care but have also been instrumental in our ongoing research efforts. We are proud to share our collaborative work that's resulted in the publication of scientific papers in Nature, NPJ Precision Oncology, Elsevier and Veterinary and Comparative Oncology, showcasing the groundbreaking insights we have gained through this remarkable journey together.
In 2024 alone, we have had the privilege of presenting our research findings in the company of some of the most respected researchers in the field at conferences such as the World Veterinary Cancer Congress (WVCC) and the American Association for Cancer Research (AACR) Annual Meeting.
FidoCure extends our heartfelt gratitude to the veterinary community, our research partners, pet parents and the entire team at FidoCure for their trust and dedication. Together, we are making a positive impact on the lives of dogs and their families.
As we move forward, FidoCure remains committed to fighting cancer on both ends of the leash. We remain committed to expanding our reach, refining our platform, and advancing canine cancer research to benefit even more dogs and humans in the future.
## Related Articles
[](https://blog.fidocure.com/fidocure-blog/aacr5years)
[Vet](https://blog.fidocure.com/fidocure-blog/tag/vet)
### [Celebrating 5 Years of Research at AACR](https://blog.fidocure.com/fidocure-blog/aacr5years)
**FidoCure by the One Health Company and Stanford University Research Shared at AACR 2024 **
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Read More](https://blog.fidocure.com/fidocure-blog/aacr5years)
[](https://blog.fidocure.com/fidocure-blog/data-first-pet-healthcare-how-fidocure-is-leveraging-big-data-to-improve-canine-cancer-outcomes)
### [Data-First Pet Healthcare: How FidoCure is Leveraging Big Data to Improve Canine Cancer Outcomes](https://blog.fidocure.com/fidocure-blog/data-first-pet-healthcare-how-fidocure-is-leveraging-big-data-to-improve-canine-cancer-outcomes)
In the fight against canine cancer, one of the most powerful tools at medicine’s disposal is data. Data can help describe genomes, uncover patterns in care and outcomes,...
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Read More](https://blog.fidocure.com/fidocure-blog/data-first-pet-healthcare-how-fidocure-is-leveraging-big-data-to-improve-canine-cancer-outcomes)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Christina K. Lopes",
"url" : "https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes"
},
"dateModified" : "2024-06-13T16:13:11.952Z",
"datePublished" : "2024-04-24T14:24:16.000Z",
"headline" : "We've Reached 5000 Patients!",
"image" : [ "https://blog.fidocure.com/hubfs/Twitter%20banner%205000%20cases%20(1).png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```